Dr Lincoln Tan is a Consultant Urologist, and accredited Robotic Surgeon at Mount Elizabeth
Hospital. He was the former Director of Urologic Oncology at the National University Hospital
(NUH) and National Cancer Institute of Singapore (NCIS) prior to joining Tan Urology. He is
currently Visiting Consultant at NUH.
Dr Tan is trained in all aspects of open and endoscopic urology and specialises in the minimally invasive treatment of urologic cancers. His particular interests is in laparoscopic and robotic-assisted surgery, particularly for the management of prostate and kidney cancer.
Dr Tan’s subspecialty interest is in the care of men with prostate cancer — advanced prostate cancer
diagnostics to reduce unnecessary prostate biopsies, and the performance of safer, more accurate prostate
biopsies. Dr Tan was the principal investigator in the first local study to validate the use of the
Prostate Health Index to better risk stratify men at risk of prostate cancer, to reduce subjecting men to
He was also one of the clinical leads that introduced free hand office based transperineal prostate biopsies into Singapore.
Dr Tan is a passionate advocate for Men’s Health and
Prostate Cancer patients. He has actively participated in
the Movember fund raising campaigns for several years,
and organised many educational talks for the public and
primary care physicians.
He remains actively involved in prostate cancer survivorship issues. He was once the organising chairman for Prostate Cancer Awareness Month, and still sits as Chairman of the Singapore Cancer Society (SCS) Prostate Cancer Survivorship Programmes Advisory Committee.
Beyond the walls of the clinic, Dr Tan strongly believes in the education of the next generation of doctors and urologists:
Dr Tan is privileged to be a faculty of the Asian Urological Surgery Training and Education Group (AUSTEG), a group of regional urologists who are passionate to share training opportunities in endourology to trainees in Asia. He also is thankful for opportunities to share his knowledge on prostate cancer care with his colleagues in the region, giving talks in countries including Indonesia, Malaysia, China, Philippines and Nepal.